pmc logo image
Logo of pnasPNAS Home page.Reference to the article.PNAS Info for AuthorsPNAS SubscriptionsPNAS About
Journal List > Proc Natl Acad Sci U S A > v.91(1); Jan 4, 1994

Formats:
Proc Natl Acad Sci U S A. 1994 January 4; 91(1): 360–364.
PMCID: PMC42947
Copyright notice
UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement.
H Nakazawa, D English, P L Randell, K Nakazawa, N Martel, B K Armstrong, and H Yamasaki
International Agency for Research on Cancer, Lyon, France.
Small right arrow pointing to: This article has been cited by other articles in PMC.
Abstract
Many human skin tumors contain mutated p53 genes that probably result from UV exposure. To investigate the link between UV exposure and p53 gene mutation, we developed two methods to detect presumptive UV-specific p53 gene mutations in UV-exposed normal skin. The methods are based on mutant allele-specific PCRs and ligase chain reactions and designed to detect CC to TT mutations at codons 245 and 247/248, using 10 micrograms of DNA samples. These specific mutations in the p53 gene have been reported in skin tumors. CC to TT mutations in the p53 gene were detected in cultured human skin cells only after UV irradiation, and the mutation frequency increased with increasing UV dose. Seventeen of 23 samples of normal skin from sun-exposed sites (74%) on Australian skin cancer patients contained CC to TT mutations in one or both of codons 245 and 247/248 of the p53 gene, and only 1 of 20 samples from non-sun-exposed sites (5%) harbored the mutation. None of 15 biopsies of normal skin from non-sun-exposed or intermittently exposed sites on volunteers living in France carried such mutations. Our results suggest that specific p53 gene mutations associated with human skin cancer are induced in normal skin by solar UV radiation. Measurement of these mutations may be useful as a biologically relevant measure of UV exposure in humans and as a possible predictor of risk for skin cancer.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
icon of scanned page 360
360
icon of scanned page 361
361
icon of scanned page 362
362
icon of scanned page 363
363
icon of scanned page 364
364
 
Images in this article
Fig. 2
Fig. 2

Fig. 2
on p.362
Fig. 3
Fig. 3

Fig. 3
on p.362
Fig. 4
Fig. 4

Fig. 4
on p.363
Click on the image to see a larger version.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Wogan GN. Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research. Environ Health Perspect. 1992 Nov;98:167–178. [PubMed]
  • Albertini RJ, O'Neill JP, Nicklas JA, Heintz NH, Kelleher PC. Alterations of the hprt gene in human in vivo-derived 6-thioguanine-resistant T lymphocytes. Nature. 316(6026):369–371. [PubMed]
  • Vogelstein B, Kinzler KW. Carcinogens leave fingerprints. Nature. 1992 Jan 16;355(6357):209–210. [PubMed]
  • Balmain A, Brown K. Oncogene activation in chemical carcinogenesis. Adv Cancer Res. 1988;51:147–182. [PubMed]
  • Dipple A, Pigott M, Moschel RC, Costantino N. Evidence that binding of 7,12-dimethylbenz(a)anthracene to DNA in mouse embryo cell cultures results in extensive substitution of both adenine and guanine residues. Cancer Res. 1983 Sep;43(9):4132–4135. [PubMed]
  • Abbott PJ, Saffhill R. DNA synthesis with methylated poly(dC-dG) templates. Evidence for a competitive nature to miscoding by O(6)-methylguanine. Biochim Biophys Acta. 1979 Mar 28;562(1):51–61. [PubMed]
  • Marion MJ, Froment O, Trépo C. Activation of Ki-ras gene by point mutation in human liver angiosarcoma associated with vinyl chloride exposure. Mol Carcinog. 1991;4(6):450–454. [PubMed]
  • Barbin A, Tenenbaum L, Toman Z, Radman M, Bartsch H. recA-independent mutagenicity induced by chloroethylene oxide in E. coli. Mutat Res. 1985 Nov–Dec;152(2-3):157–159. [PubMed]
  • Creech JL, Jr, Johnson MN. Angiosarcoma of liver in the manufacture of polyvinyl chloride. J Occup Med. 1974 Mar;16(3):150–151. [PubMed]
  • Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991 Apr 4;350(6317):427–428. [PubMed]
  • Ozturk M. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet. 1991 Nov 30;338(8779):1356–1359. [PubMed]
  • Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Pontén J. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10124–10128. [PubMed]
  • Seidman MM, Bredberg A, Seetharam S, Kraemer KH. Multiple point mutations in a shuttle vector propagated in human cells: evidence for an error-prone DNA polymerase activity. Proc Natl Acad Sci U S A. 1987 Jul;84(14):4944–4948. [PubMed]
  • Pierceall WE, Mukhopadhyay T, Goldberg LH, Ananthaswamy HN. Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas. Mol Carcinog. 1991;4(6):445–449. [PubMed]
  • Somers KD, Merrick MA, Lopez ME, Incognito LS, Schechter GL, Casey G. Frequent p53 mutations in head and neck cancer. Cancer Res. 1992 Nov 1;52(21):5997–6000. [PubMed]
  • Kress S, Sutter C, Strickland PT, Mukhtar H, Schweizer J, Schwarz M. Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res. 1992 Nov 15;52(22):6400–6403. [PubMed]
  • Nakazawa H, Aguelon AM, Yamasaki H. Relationship between chemically induced Ha-ras mutation and transformation of BALB/c 3T3 cells: evidence for chemical-specific activation and cell type-specific recruitment of oncogene in transformation. Mol Carcinog. 1990;3(4):202–209. [PubMed]
  • Kumar R, Sukumar S, Barbacid M. Activation of ras oncogenes preceding the onset of neoplasia. Science. 1990 Jun 1;248(4959):1101–1104. [PubMed]
  • Nikitin AYu, Ballering LA, Lyons J, Rajewsky MF. Early mutation of the neu (erbB-2) gene during ethylnitrosourea-induced oncogenesis in the rat Schwann cell lineage. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):9939–9943. [PubMed]
  • Molès JP, Moyret C, Guillot B, Jeanteur P, Guilhou JJ, Theillet C, Basset-Sèguin N. p53 gene mutations in human epithelial skin cancers. Oncogene. 1993 Mar;8(3):583–588. [PubMed]
  • Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, Simon JA, Halperin AJ, Baden HP, Shapiro PE, Bale AE, et al. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A. 1993 May 1;90(9):4216–4220. [PubMed]
  • Kanjilal S, Pierceall WE, Cummings KK, Kripke ML, Ananthaswamy HN. High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. Cancer Res. 1993 Jul 1;53(13):2961–2964. [PubMed]
  • Reid TM, Loeb LA. Mutagenic specificity of oxygen radicals produced by human leukemia cells. Cancer Res. 1992 Mar 1;52(5):1082–1086. [PubMed]
  • Hawley-Nelson P, Sullivan JE, Kung M, Hennings H, Yuspa SH. Optimized conditions for the growth of human epidermal cells in culture. J Invest Dermatol. 1980 Aug;75(2):176–182. [PubMed]
  • Suzuki Y, Sekiya T, Hayashi K. Allele-specific polymerase chain reaction: a method for amplification and sequence determination of a single component among a mixture of sequence variants. Anal Biochem. 1991 Jan;192(1):82–84. [PubMed]
  • D'Aquila RT, Bechtel LJ, Videler JA, Eron JJ, Gorczyca P, Kaplan JC. Maximizing sensitivity and specificity of PCR by pre-amplification heating. Nucleic Acids Res. 1991 Jul 11;19(13):3749. [PubMed]
  • Törmänen VT, Pfeifer GP. Mapping of UV photoproducts within ras proto-oncogenes in UV-irradiated cells: correlation with mutations in human skin cancer. Oncogene. 1992 Sep;7(9):1729–1736. [PubMed]
  • Wei Q, Matanoski GM, Farmer ER, Hedayati MA, Grossman L. DNA repair and aging in basal cell carcinoma: a molecular epidemiology study. Proc Natl Acad Sci U S A. 1993 Feb 15;90(4):1614–1618. [PubMed]
  • Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 1991 Jun 15;51(12):3075–3079. [PubMed]
  • Meuth M. The structure of mutation in mammalian cells. Biochim Biophys Acta. 1990 Jun 1;1032(1):1–17. [PubMed]
  • Vrieling H, Van Rooijen ML, Groen NA, Zdzienicka MZ, Simons JW, Lohman PH, van Zeeland AA. DNA strand specificity for UV-induced mutations in mammalian cells. Mol Cell Biol. 1989 Mar;9(3):1277–1283. [PubMed]
  • Kricker A, English DR, Randell PL, Heenan PJ, Clay CD, Delaney TA, Armstrong BK. Skin cancer in Geraldton, Western Australia: a survey of incidence and prevalence. Med J Aust. 1990 Apr 16;152(8):399–407. [PubMed]
  • Kripke ML, Cox PA, Alas LG, Yarosh DB. Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7516–7520. [PubMed]
Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of
National Academy of Sciences

PubMed articles by these authors

Links